1. Home
  2. MCHX vs ASRT Comparison

MCHX vs ASRT Comparison

Compare MCHX & ASRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MCHX
  • ASRT
  • Stock Information
  • Founded
  • MCHX 2003
  • ASRT 1995
  • Country
  • MCHX United States
  • ASRT United States
  • Employees
  • MCHX N/A
  • ASRT N/A
  • Industry
  • MCHX Business Services
  • ASRT Biotechnology: Pharmaceutical Preparations
  • Sector
  • MCHX Consumer Discretionary
  • ASRT Health Care
  • Exchange
  • MCHX Nasdaq
  • ASRT Nasdaq
  • Market Cap
  • MCHX 84.3M
  • ASRT 78.3M
  • IPO Year
  • MCHX 2004
  • ASRT 1997
  • Fundamental
  • Price
  • MCHX $2.00
  • ASRT $0.86
  • Analyst Decision
  • MCHX
  • ASRT Strong Buy
  • Analyst Count
  • MCHX 0
  • ASRT 4
  • Target Price
  • MCHX N/A
  • ASRT $3.19
  • AVG Volume (30 Days)
  • MCHX 31.4K
  • ASRT 367.0K
  • Earning Date
  • MCHX 03-13-2025
  • ASRT 03-10-2025
  • Dividend Yield
  • MCHX N/A
  • ASRT N/A
  • EPS Growth
  • MCHX N/A
  • ASRT N/A
  • EPS
  • MCHX N/A
  • ASRT N/A
  • Revenue
  • MCHX $48,594,000.00
  • ASRT $125,763,000.00
  • Revenue This Year
  • MCHX N/A
  • ASRT N/A
  • Revenue Next Year
  • MCHX $4.63
  • ASRT $1.84
  • P/E Ratio
  • MCHX N/A
  • ASRT N/A
  • Revenue Growth
  • MCHX N/A
  • ASRT N/A
  • 52 Week Low
  • MCHX $1.11
  • ASRT $0.73
  • 52 Week High
  • MCHX $2.40
  • ASRT $1.80
  • Technical
  • Relative Strength Index (RSI)
  • MCHX 53.54
  • ASRT 55.35
  • Support Level
  • MCHX $1.88
  • ASRT $0.78
  • Resistance Level
  • MCHX $2.04
  • ASRT $0.88
  • Average True Range (ATR)
  • MCHX 0.09
  • ASRT 0.03
  • MACD
  • MCHX -0.00
  • ASRT 0.01
  • Stochastic Oscillator
  • MCHX 78.57
  • ASRT 82.60

About MCHX Marchex Inc. Class B

Marchex Inc is a conversational analytics and solutions company that helps businesses connect, drive, measure, convert callers into customers, and connect the voice of the customer to their business. It delivers data insights and incorporates artificial intelligence (AI)-powered functionality that drives insights and solutions to help companies find, engage, and support their customers across voice and text-based communication channels. The group enables sales and marketing teams to deliver the buying experiences that today's customers expect. The company generates the majority of its revenues from core analytics and solutions services. The company operates in the United States, Canada, and other countries.

About ASRT Assertio Holdings Inc.

Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults of age or older; and Zipsor, liquid-filled capsules for relief of mild to moderate pain.

Share on Social Networks: